Related Experiment Videos

The search for meaningful prognostic markers in diffuse large B-cell lymphoma

American Journal of Clinical Pathology

|April 11, 2001

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance).

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy.

Leukemia·2017

2016 WHO Classification update-What's new in lymphoid neoplasms.

International journal of laboratory hematology·2017

Clinicopathologic and molecular characterization of myeloid neoplasms with isolated t(6;9)(p23;q34).

International journal of laboratory hematology·2017

Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.

Leukemia·2016

Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium.

Leukemia·2015

See all related articles